A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301 (IMPROVE-Open)
A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of Bupivacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Open Colectomy
Sponsor: Pacira Pharmaceuticals, Inc
Terminated
Slow enrollment
Other terminated trials from Pacira Pharmaceuticals, Inc
- Osteoarthritis of Hip · Phase PHASE2 · Oct 2025
- Post-Operative Pain Management · Phase NA · Jul 2022
- Healthy · Phase PHASE1 · Dec 2020
- Postoperative Pain Management · Phase PHASE4 · Aug 2020
- Osteoarthritis, Hip · Phase PHASE3 · Aug 2019
More terminations from Pacira Pharmaceuticals, Inc
Other Bowel Obstruction trials with similar outcome
Listed as NCT01507220, this PHASE4 trial focuses on Bowel Obstruction and remains terminated or withdrawn. Sponsored by Pacira Pharmaceuticals, Inc, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pacira Pharmaceuticals, Inc
- Registrat-Mapi
For direct contact, visit the study record on ClinicalTrials.gov .